An overview of statistical planning to address subgroups in confirmatory clinical trials

作者: Gary G. Koch , Todd A. Schwartz

DOI: 10.1080/10543406.2013.856021

关键词:

摘要: The effects of treatments within demographic and clinical subgroups patients are major interest in most confirmatory trials. Potential factors for defining include gender, age, disease severity, geographic region. A statistical issue the interpretation treatment comparisons is whether role a subgroup inferential, supportive, or exploratory through respectively corresponding to primary, key secondary, hypothesis-generating assessment. This article discusses planning control type 1 error multiple that correspond scope prespecified inferential subgroups, it provides some suggestions addressing 2 can pertain supportive subgroups. Treatment without priori specification should always have very cautious accounts how random variation influence their pattern results, although sugge...

参考文章(22)
Randall D. Tobias, Russell D. Wolfinger, Dror Rom, Multiple Comparisons and Multiple Tests Using the SAS System ,(1999)
Alex Dmitrienko, Ajit C. Tamhane, Gatekeeping procedures with clinical trial applications Pharmaceutical Statistics. ,vol. 6, pp. 171- 180 ,(2007) , 10.1002/PST.291
Laurence D. Robinson, Nicholas P. Jewell, Some surprising results about covariate adjustment in logistic regression models International Statistical Review. ,vol. 59, pp. 227- 240 ,(1991) , 10.2307/1403444
J. Hasford, P. Bramlage, G. Koch, W. Lehmacher, K. Einhäupl, P.M. Rothwell, Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. Journal of Clinical Epidemiology. ,vol. 63, pp. 1298- 1304 ,(2010) , 10.1016/J.JCLINEPI.2009.10.009
Yoav Benjamini, Yosef Hochberg, Multiple Hypotheses Testing with Weights Scandinavian Journal of Statistics. ,vol. 24, pp. 407- 418 ,(1997) , 10.1111/1467-9469.00072
Gary G. Koch, Discussion of “p-value adjustments for subgroup analyses” Journal of Biopharmaceutical Statistics. ,vol. 7, pp. 323- 331 ,(1997) , 10.1080/10543409708835190
H. M. James Hung, Sue-Jane Wang, Robert T. O'Neill, Consideration of regional difference in design and analysis of multi‐regional trials Pharmaceutical Statistics. ,vol. 9, pp. 173- 178 ,(2010) , 10.1002/PST.440
Siying Li, Michael A. Hussey, Todd A. Schwartz, Gary G. Koch, A multistage analysis strategy for a clinical trial to assess successively more stringent criteria for a primary endpoint with a low event rate Pharmaceutical Statistics. ,vol. 12, pp. 65- 73 ,(2013) , 10.1002/PST.1554
Gerhard Hommel, Frank Bretz, Willi Maurer, Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research. Journal of Biopharmaceutical Statistics. ,vol. 21, pp. 595- 609 ,(2011) , 10.1080/10543406.2011.552879